SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-12-071891
Filing Date
2012-10-29
Accepted
2012-10-29 13:42:50
Documents
11
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a12-19056_110q.htm 10-Q 2406340
2 EX-31.1 a12-19056_1ex31d1.htm EX-31.1 10184
3 EX-31.2 a12-19056_1ex31d2.htm EX-31.2 11120
4 EX-32.1 a12-19056_1ex32d1.htm EX-32.1 5567
5 EX-32.2 a12-19056_1ex32d2.htm EX-32.2 7319
  Complete submission text file 0001104659-12-071891.txt   16434038

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT celg-20120930.xml EX-101.INS 2401294
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT celg-20120930.xsd EX-101.SCH 151120
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT celg-20120930_cal.xml EX-101.CAL 95954
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT celg-20120930_lab.xml EX-101.LAB 2530199
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT celg-20120930_pre.xml EX-101.PRE 1073780
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT celg-20120930_def.xml EX-101.DEF 730971
Mailing Address 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address 86 MORRIS AVENUE SUMMIT NJ 07901 (908)673-9000
CELGENE CORP /DE/ (Filer) CIK: 0000816284 (see all company filings)

IRS No.: 222711928 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34912 | Film No.: 121166500
SIC: 2834 Pharmaceutical Preparations